BioInvent Announces Publication of Data in Leading Cancer Journal Immunity
Go back to BioInvent Announces Publication of Data in Leading Cancer Journal Immunity| (NYSE: BINV) | Delayed: 45.95 +0.46 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.49 | 52 Week High | $ | |||
| Open | $45.97 | 52 Week Low | $ | |||
| Day High | $46.05 | P/E | N/A | |||
| Day Low | $45.82 | EPS | $ | |||
| Volume | 19,093 | |||||

